Results of the U.S. Food and Drug Administration Continued Access Clinical Trial of the GORE HELEX Septal Occluder for Secundum Atrial Septal Defect

Study Questions:

What are the immediate, 1-, and 5-year results for patients undergoing closure of secundum atrial septal defect (ASD) with the GORE HELEX Septal Occluder?